Dr Reddy's Q1 net plunges 78%
BS 200 SCORECARD
|Dr Reddy's Laboratories has reported a staggering 78 per cent drop its net profit for the first quarter ended June 30, hit mainly by a fall in rupee. Net profit for the quarter was Rs 17.3 crore compared with Rs 79.2 crore for the same period last year.
|The company said it's foreign exchange loss stood at Rs 32.3 crore because of the change in the rupee-dollar parity. Total revenues for the quarter inched up six per cent to touch Rs 510.8 crore as compared to Rs 481.20 crore for the corresponding quarter last year.
|Diluted EPS for the quarter slid to Rs 2.27 as against Rs 10.35 in the same quarter last year. Dr Reddy's CEO G V Prasad said the quarter's results were 'not encouraging' and that during the quarter the company faced increased pricing pressure on two of its best selling generic drugs in the US market, Fluoxetine and Tizanadine. |
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
First Published: Wed, July 28 2004. 00:00 IST